Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01349049. IPD Sharing: YES. Countries: 1. Publications: 1.
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03552029. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00989261. IPD Sharing: YES. Countries: 9. Publications: 1.
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02668653. IPD Sharing: YES. Countries: 28. Publications: 4.
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03512197. IPD Sharing: YES. Countries: 20. Publications: 0.
A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy
ClinicalTrials.gov study NCT04266795. IPD Sharing: YES. Countries: 5. Publications: 1.
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
ClinicalTrials.gov study NCT02039726. IPD Sharing: YES. Countries: 19. Publications: 3.
Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01898793. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01829503. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01786343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02588092. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Sy
ClinicalTrials.gov study NCT01835587. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT03182244. IPD Sharing: YES. Countries: 5. Publications: 1.
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02152956. IPD Sharing: Not stated. Countries: 8. Publications: 1.
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02545283. IPD Sharing: Not stated. Countries: 19. Publications: 1.
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
ClinicalTrials.gov study NCT01025154. IPD Sharing: Not stated. Countries: 1. Publications: 1.
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01266083. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01912274. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).
ClinicalTrials.gov study NCT03298984. IPD Sharing: NO. Countries: 1. Publications: 1.
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction
ClinicalTrials.gov study NCT02348489. IPD Sharing: Not stated. Countries: 24. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.